Question · asked by 1 review
Pregabalin vs placebo at end of treatment: Fatigue
- Population
- patients with fibromyalgia
- Intervention
- Pregabalin
- Comparison
- placebo at end of treatment
- Outcome
- Fatigue
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Pregabalin vs placebo at end of treatment Fatigue (1‐50 scale) Higher scores indicate higher fatigue levels · People with fibromyalgia Anticonvulsants for fibromyalgia (2013) · Cochrane Headline outcomes only | no estimate extracted | 5 studies · 3195 participants | High |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Anticonvulsants for fibromyalgia 2013 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.